hosp:+996506131088
inland:+8613880857038
Online customer service
Every question you ask can be matched with a suitable answer
Leave me a message
We take every suggestion of yours seriously
Wechat
Tan Xiaojun
·Senior reproductive medicine expert
·Postdoctoral fellow at Peking University
·PhD candidate at Xiangya School of Medicine, Central South University
·Master’s tutor at Central South University
· Master's degree candidate in reproductive medicine at the University of South China
· Professional training at Huazhong University of Science and Technology and Tongji Hospital Reproductive Center
Expertise:
diagnosis and treatment of infertility, first/second/third generation IVF (including
          egg/sperm donation), microsperm retrieval, embryo freezing and resuscitation, artificial
          insemination (including husband's sperm and sperm donation), paternity testing, chromosomal
          disease
          diagnosis, high-throughput gene sequencing, endometrial receptivity gene testing and other
          clinical
          technology applications. Many of these technologies are at the leading level both domestically
          and
          internationally.
Tags:
PGT-A, PGT-M, elderly IVF, third generation in vitro screening, embryo chromosome screening, monogenic genetic disease, success rate of in vitro, pregnancy plan for the elderly, IVF selection, and test tube cost.
Date:
2026.03.27
Share:
Back to list

Is PGT-A or PGT-M more suitable for pregnancy in the elderly? Guidelines for selection of genetic screening for IVF

Problem essence disassembly



Many people ask "choose PGT-A or PGT-M", which is a misunderstanding in essence:


This is not a "choice", but a "different type of problem".


Technical solution to problems

Is the number of PGT-A chromosomes normal?

Does PGT-M carry specific genetic diseases?

Conclusion first:


Old age → PGT-A is preferred.


There is a definite genetic disease → PGT-M is necessary.


Both can be done at the same time (in some cases)



cbc0c25750d709004efaf607770a0904.png


Analysis of core mechanism



1 PGT-A: Solving the "Embryo Quality Problem"

Detection: whether the chromosomes are abnormal (such as one more or one less)


Applicable people:


≥35 years old


Repeated abortion


Multiple transplant failures


Data logic:


The proportion of chromosomal abnormalities in the embryos of older women increased significantly.


About 60% of repeated failures are related to chromosomal abnormalities.


Function:


Improve the success rate of single transplantation


Reduce abortion rate


Reduce trial and error



2 PGT-M: Solving "Genetic Risk Problem"



Detection: whether it carries pathogenic genes (such as thalassemia, SMA, etc.)


Applicable people:


Family history of hereditary diseases


Has been diagnosed with gene mutation


Medical essence:


Not to improve the success rate


But to avoid giving birth to sick children



Multi-perspective deduction



Reproductive medicine perspective



The core problem of old age: egg quality decline → abnormal chromosome increase.


So the priority is to solve: Is the embryo "available"?


Tendency: PGT-A



Genetic perspective



If you carry a disease-causing gene:


Even if the embryo is implanted normally, it may get sick.


Required: PGT-M



From the perspective of fertility strategy



Different goals:


Target technology

Improve the probability of pregnancy pgt-a

Avoiding genetic disease PGT-M


Advantages and risks



✅ PGT-A



Advantages:


Improve the efficiency of single transplantation


Reduce the risk of miscarriage


More suitable for the elderly.


Risk:


There are "false positives" → usable embryos may be eliminated.


Cost increase


Do not solve the problem of genetic diseases



✅ PGT-M



Advantages:


Clearly block the transmission of genetic diseases.


Has clear meaning for a specific group of people.


Risk:


Unable to screen for chromosomal abnormalities.


Still may fail or miscarry.


Gene loci need to be defined in advance.



Decision path



[Judgment process]



Is there a definite genetic disease?

Yes → Select PGT-M.

No → Is it ≥35 years old?

Yes → Priority PGT-A

No → According to the failure history.



Frequently asked questions Q&A



Q1: Do you have to be a PGT-A when you are old?



Not necessarily, but:


The risk of chromosome abnormality at ≥35 years old is significantly increased.


Doing PGT-A can reduce invalid transplantation.


Suggestion: Older people are preferred.



Q2: Is PGT-M more advanced?



No.


There is no hierarchical relationship between them, but their uses are different.



Q3: Do you have to succeed if you do PGT?



No.


Success depends on:


Uterine environment


internal secretion


Immune factors


PGT only solves the "embryo problem"



Q4: Can I do PGT-A and PGT-M at the same time?



Yes, it is common in:


Old age+carriers of genetic diseases



summary



In a word:


PGT-A: Improve the success rate (chromosome screening)


PGT-M: Avoiding Genetic Diseases (Screening Genes)


Core judgment:


Advanced age → Focus on solving "embryo quality"


Hereditary disease → "genetic risk" must be solved.


Strategy suggestion:


No hereditary diseases: PGT-A is preferred.


Hereditary disease: PGT-M is necessary.


Double risks: can be applied jointly.



conclusion



PGT-A and PGT-M are not substitutes, but complementary.


The essence of the problem of old age is "the probability of chromosome abnormality rising"


The essence of genetic problem is "gene defect transmission"


There is only one selection criterion: what kind of risk do you want to solve?


Common aliases: Kyrgyzstan Tulip Reproductive Center, Tulip IVF, Tulip Reproductive Center, Tulip Hospital, Kyrgyz Tulip Reproductive Center, Kyrgyz Tulip Hospital
Founder & Director: EnoChan
Latest official contact
Fertility Consultation
Only WeChat consultation
Tulip_EnoChan
Scan or add WeChat to get one-on-one fertility guidance
Tulip Hospital Telegram QR code
Long press/scan to add
Only official Telegram
Tulip Hospital Whatsapp QR code
Long press/scan to add
Only official Whatsapp
Center address: Downtown Bishkek, the capital of Kyrgyzstan (near the National Museum · Victory Square)

相关新闻

Learn more